Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
26
27
28
29
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
17
18
20
21
22
24
25
26
27
28
29
30
1
2
3
4
5
6
BARDA Industry Day
2020-10-27    
12:00 am
Organized by BARDA BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities, interact with BARDA [...]
The Future of Insurance USA
2020-11-16 - 2020-11-18    
All Day
We’re excited to announce today the launch of The Future of Insurance USA (November 16-18 2020), an online 3-day conference by Reuters Events. The Future [...]
Geneva Health Forum 2020
2020-11-16 - 2020-11-18    
12:00 am
Geneva Health Forum 2020 The 8th edition of the Geneva Health Forum will take place from 16-18 November 2020. The thematic of the year will [...]
19 Nov
2020-11-19 - 2020-11-20    
12:00 am
The stage is set for a paradigm shift in healthcare. The opportunity exists to redefine healthcare in a way that transforms patient outcomes, drives efficiency [...]
The 2nd Saudi International Pharma Expo
2020-11-23 - 2020-11-24    
All Day
ABOUT THE 2ND SAUDI INTERNATIONAL PHARMA EXPO SAUDI INTERNATIONAL PHARMA EXPO offers you an EXCELLENT opportunity to expand your business in Saudi Arabia and international [...]
World Congress on Medical Toxicology
2020-12-01 - 2020-12-02    
12:00 am
World Congress on Medical Toxicology Medical Toxicology Pharma 2020 provides a global platform to meet and develop interpersonal relationship with the world’s leading toxicologists, pharmacologists, [...]
01 Dec
2020-12-01 - 2020-12-02    
All Day
International Conference on Food Technology & Beverages” at Kyoto, Japan in the course of Kyoto, Japan, December, 01-02, 2020 Theme of the Food Tech 2020 [...]
Biomedical, Bio Pharma and Clinical Research
2020-12-03 - 2020-12-04    
12:00 am
Biomedical, Bio Pharma and Clinical Research Conference Series LLC LTD cordially invites you to be a part of “2nd International Conference on Biomedical, Bio Pharma [...]
Events on 2020-10-27
BARDA Industry Day
27 Oct 20
Events on 2020-11-16
Events on 2020-11-19
Events on 2020-11-23
The 2nd Saudi International Pharma Expo
23 Nov 20
King Abdullah
Events on 2020-12-03
Latest News

Keep Emerson (EMR) in Your Portfolio: Here’s Why

Emerson Electric Co is experiencing robust demand across multiple sectors, especially in process and hybrid markets, which is propelling its order growth. Management foresees sustained strong sales in these markets throughout fiscal 2024, driven by the resilience of chemical, life sciences, LNG, metals and mining, and sustainability and decarbonization sectors.

In the Intelligent Devices segment, Emerson is observing strong performance in measurement and analytical, as well as final control businesses, supported by demand in hybrid and process markets. With optimism prevailing across its segments, Emerson anticipates a 12.5-14.5% surge in net sales for the second quarter of fiscal 2024 compared to the prior year.

Emerson is actively pursuing expansion through acquisitions. Recent acquisitions such as Afag and Flexim have bolstered its capabilities in factory automation, battery manufacturing, automotive, electronics, and automation portfolio. Additionally, the acquisition of National Instruments has strengthened its footprint in semiconductor, electronics, transportation, electric vehicles, and aerospace & defense sectors.

The company is committed to enhancing shareholder value through dividends and share repurchases. In the first quarter of fiscal 2024, it disbursed dividends totaling $300 million and repurchased common stocks worth $175 million. Furthermore, Emerson raised its dividend by 1% in October 2023.
User

However, EMR has noted a decline in performance within its test and measurement business segment under the Software and Control division. In the initial fiscal quarter, orders for this sector dropped by 17% compared to the preceding year, attributed to sustained softness in discrete and semiconductor markets, alongside continued challenges in China.

The company’s profitability has been impacted by escalating operational costs and expenditures. For example, in the first fiscal quarter, its cost of sales experienced a significant increase of 25.6% year over year, while selling, general, and administrative expenses saw a rise of 24%. Consequently, the pre-tax margin for the quarter decreased to 3.4%, down from 12.5% in the corresponding fiscal quarter of the previous year.